Forgot your password? Enter the email address you used to create your account to initiate a password reset.
Pulmonary vascular disease has traditionally been handled by cardiology or pulmonary specialists, with relatively little collaboration. This has resulted in inferior treatment, inconvenience to the patient and difficulties for treating physicians.
Cardiopulmonary disease affects many different patient populations with a variety of disease states:
In an effort to provide a successful model for the diagnosis and treatment of cardiopulmonary disease at UPMC, the Pulmonary Hypertension Research Center integrates specialists in cardiology, pulmonary and critical care medicine, and transplant medicine.
The Pulmonary Hypertension Research Center is one of the largest programs in the country, offering patients full access to state-of-the-art diagnostics, therapeutics, and opportunities to participate in clinical research.
While the evaluation of affected patients is complex, the UPMC Comprehensive Pulmonary Hypertension Program, offers patients full access to:
The program also is researching new technologies to evaluate right heart function and new strategies to identify risk factors that portend a poor outcome in patients with pulmonary hypertension.
Researchers in the Vascular Medicine Institute and the PHRC focus on pathogenesis and treatment of models of pulmonary arterial hypertension, using state of the art imaging and hemodynamic measures.